Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes

Numerous studies suggest that rapamycin treatment promotes insulin resistance, implying that rapamycin could have negative effects on patients with, or at risk for, type 2 diabetes (T2D). New evidence, however, indicates that rapamycin treatment produces some benefits to energy metabolism, even in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Reifsnyder, Peter C., Flurkey, Kevin, Te, Austen, Harrison, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191889/
https://www.ncbi.nlm.nih.gov/pubmed/27922820
http://dx.doi.org/10.18632/aging.101117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191889/
https://www.ncbi.nlm.nih.gov/pubmed/27922820
http://dx.doi.org/10.18632/aging.101117

Ejemplares similares